Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-29
2000-08-29
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546221, A01N 4340
Patent
active
06110941&
ABSTRACT:
Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones are described, as are a method of preparing them and their use in drugs.
REFERENCES:
patent: 5356406 (1994-10-01), Ciganek et al.
patent: 5463063 (1995-10-01), Muller
patent: 5480892 (1996-01-01), Ciganek et al.
patent: 5698579 (1997-12-01), Muller
Muller et al., J. Med. Chem., 39: 3238-40 (1996).
Teubert et al., Arch. Pharm. Pharm. Med. Checm., 331: 7-12 (1998).
Chemical Abstracts 66: 94788a (1967).
Chemical Abstracts 123: 216835b (1995).
Chemical Abstracts 124: 45119r (1996).
Masuda et al., "Double-Masked Trial of Cyclosporin Versus Colchicine and Long-Term Open Study of Cyclosporin in Behcet's Disease", The Lancet, May 20, 1989, pp. 1093-1095.
G. Tappeiner, "Therapie des Lupus Erythematodes 1994", (Therapy of Lupus Erythematosus 1994), H+G, vol. 69, 1994, pp. 816-822.
Eger Kurt
Teubert Uwe
Winter Werner
Wnendt Stephan
Zimmer Oswald
Covington Raymond
Gruenenthal GmbH
Kight John
LandOfFree
Compounds analogous to thalidomide from the class comprising pip does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds analogous to thalidomide from the class comprising pip, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds analogous to thalidomide from the class comprising pip will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1250296